References
Bergenstal RM, Garg S, Weinzimer SA, et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with Type 1 diabetes. JAMA 316:1407–1408
Tauschmann M, Thabit H, Bally L et al (2018) Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet 392:1321–1329
FDA News Release. FDA approves first automated insulin delivery device for Type 1 diabetes. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm522974.htm
Bally L, Thabit H, Hartnell S et al (2018) Closed-loop insulin delivery for glycemic control in noncritical care. N Engl J Med 379:547–556
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no duality of interest.
Human and animal rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Informed consent
The patient gave his signed consent for the material presented in the publication.
Additional information
Managed By Antonio Secchi.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Holstein, A., Bolli, B. Normoglycaemic control with a selfmade fully closed-loop insulin delivery system during emergency surgery: an extemporaneous stress test. Acta Diabetol 56, 807–809 (2019). https://doi.org/10.1007/s00592-019-01321-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-019-01321-w